Long-term response of gemcitabine plus docetaxel chemotherapy regimen for extraskeletal osteosarcoma: A case report

about

Pancreatic Extraskeletal Osteosarcoma Metastasizing to the Scalp.Progress in the chemotherapeutic treatment of osteosarcoma

P2860

Q55217332-5AB9257A-8CDD-4767-B2C2-566BC50C74D9 Q58572917-44A53C81-7EEE-4545-A605-913C37164492

P2860

Long-term response of gemcitabine plus docetaxel chemotherapy regimen for extraskeletal osteosarcoma: A case report

Item

http://www.wikidata.org/entity/Q35758538

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Long-term response of gemcitab ...... al osteosarcoma: A case report

@ast

Long-term response of gemcitab ...... al osteosarcoma: A case report

@en

type

Item

label

Long-term response of gemcitab ...... al osteosarcoma: A case report

@ast

Long-term response of gemcitab ...... al osteosarcoma: A case report

@en

prefLabel

Long-term response of gemcitab ...... al osteosarcoma: A case report

@ast

Long-term response of gemcitab ...... al osteosarcoma: A case report

@en

P1476

Long-term response of gemcitab ...... al osteosarcoma: A case report

@en

P2093

Antonio Cramarossa

http://www.w3.org/2001/XMLSchema#string

Michele Guida

http://www.w3.org/2001/XMLSchema#string

Michele Traversa

http://www.w3.org/2001/XMLSchema#string

Ondina Popescu

http://www.w3.org/2001/XMLSchema#string

Sabino Strippoli

http://www.w3.org/2001/XMLSchema#string

Vito Lorusso

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis.

Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma.

Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.

Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.

Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.

Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma.

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

P304

2567-2571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2015.3111

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275258578

http://www.w3.org/2001/XMLSchema#string

P698

26137107

http://www.w3.org/2001/XMLSchema#string

P932

4473531

http://www.w3.org/2001/XMLSchema#string

Long-term response of gemcitabine plus docetaxel chemotherapy regimen for extraskeletal osteosarcoma: A case report

about

P2860

P2860

Long-term response of gemcitabine plus docetaxel chemotherapy regimen for extraskeletal osteosarcoma: A case report

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932